Eslicarbazepine acetate (trade names Aptiom in the US, Zebinix in Europe, Exalief in Russia), abbreviated as ESL, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or adjunctive therapy (additional therapy) for partial-onset seizures epilepsy....Wikipedia

 

 

Manufacturer's Website: Aptiom                                                                                                             Average retail cost: $861/month

 

 

 

Search Terms: Aptiom, eslicarbazepine acetate, seizures, anticonvulsant, epilepsy